Our previous study unveiled that oncogene TWIST1 interacted with DNA methyltransferase 3a (DNMT3a) to regulate the decitabine (DAC) resistance in MDS/AML. The gene discussed is DNMT3A; the disease is myelodysplastic syndrome.